Yonsei Med J.  1999 Apr;40(2):118-123. 10.3349/ymj.1999.40.2.118.

The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients

Affiliations
  • 1Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA.
  • 2Department of Urology, Yonsei University College of Medicine, Seoul. leedohn@yumc.yonsei.ac.kr
  • 3Department of Urology, Soonchunhyang Medical School, Korea.

Abstract

Transforming growth factor-beta (TGF-beta), a pleiotropic growth factor, is a potent inhibitor of cellular proliferation in cells of epithelial origin. Recently, it has been suggested that a loss of sensitivity to TGF-beta through a loss of expression of TGF-beta receptors T beta R-I and T beta R-II--is associated with tumor initiation and progression. Therefore, to investigate the relationship between TGF-beta receptors expression and carcinogenesis of bladder TCC, this study examined the expression of T beta R-I and T beta R-II in 46 bladder TCC patients using immunohistochemistry. Since histopathological grade is a widely accepted marker of prognosis, the results were compared in relation to the three grades of bladder TCC. The results demonstrated that the loss of TGF-beta receptors expression is associated with increasing histopathological grades of bladder TCC. Specifically, both T beta R-I and T beta R-II were readily detected in all 10 normal bladder mucosa specimens. Likewise, all 6 specimens of grade I TCC samples expressed high levels of both TGF-beta receptors. However, among grade II TCC samples, T beta R-I and T beta R-II were detected in 78% and 89%, respectively: among grade III TCC samples, T beta R-I and T beta R-II were detected in 45% and 41%, respectively. These results suggested that loss of sensitivity to TGF-beta may play a role in the progression of TCC from low to high grade disease.

Keyword

Bladder transitional cell carcinoma; TGF-beta receptor; tumor grade

MeSH Terms

Adult
Aged
Bladder Neoplasms/pathology*
Bladder Neoplasms/metabolism*
Carcinoma, Transitional Cell/pathology*
Carcinoma, Transitional Cell/metabolism*
Human
Middle Age
Receptors, Transforming Growth Factor beta/metabolism*
Reference Values
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr